GenSight Biologics S.A. (LON:0RIM)
London · Delayed Price · Currency is GBP · Price in EUR 0.1665
-0.0026 (-1.54%)
At close: Aug 21, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 21.63 million as of August 25, 2025. Its market cap has decreased by -29.21% in one year.
Market Cap
21.63M
Enterprise Value
36.05M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 21.63M, a decrease of -89.81%. That is a compound annual growth rate of -22.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 21.63M | -20.86% |
| Dec 31, 2024 | 27.33M | 22.73% |
| Dec 29, 2023 | 22.27M | -83.82% |
| Dec 30, 2022 | 137.66M | -35.82% |
| Dec 31, 2021 | 214.49M | -21.34% |
| Dec 31, 2020 | 272.69M | 296.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.59B |
| HSBC Holdings | 167.19B |
| Shell | 157.59B |
| Unilever | 116.15B |
| British American Tobacco p.l.c. | 94.23B |
| Rolls-Royce Holdings | 87.64B |
| Rio Tinto Group | 77.77B |
| RELX PLC | 65.51B |